Osteoinductive pharmaceutical formulations
CA 2085750 C · Owner: Genetics Institute, Inc. · Inventors: Kriz, Mary J.; Gerhart, Tobin N.; Wang, Elizabeth A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Osteoinductive pharmaceutical Formulations comprising antifibrinolytic agents such as epsilon amino acid caproic acid or other lysine analogues or serine protease inhibitors and cartilage and/or bone inductive proteins are disclosed. These formulations are useful in the treatment of cartilage and/or bone defects.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 18, 1991 and granted February 18, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 18, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 18, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.